These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17083953)

  • 1. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
    Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
    Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS
    J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J; Tolonen A; Mattila S; Turpeinen M
    Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
    Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
    J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
    Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase.
    Feisst C; Albert D; Verotta L; Werz O
    Med Chem; 2005 May; 1(3):287-91. PubMed ID: 16787324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
    Nahrstedt A; Butterweck V
    J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P
    CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperforin.
    Beerhues L
    Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD; Naït-Si Y
    Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
    Weber CC; Kressmann S; Fricker G; Müller WE
    Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.